Sensei Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 11/14/2024 | 650,000 | $388,700 | 0.00% | 2.59% |
| VANGUARD GROUP INC | 11/13/2024 | 618,757 | $370,017 | 0.00% | 2.46% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 215,572 | $128,912 | -3.67% | 0.86% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 172,835 | $103,355 | 0.00% | 0.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 163,139 | $97,574 | 0.00% | 0.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 90,428 | $54,076 | 100.00% | 0.36% |
| CITADEL ADVISORS LLC | 11/14/2024 | 66,044 | $39,495 | 329.81% | 0.26% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 47,900 | $28,644 | -38.51% | 0.19% |
| NATIONAL BANK OF CANADA /FI/ | 11/15/2024 | 45,575 | $27,254 | 355.75% | 0.18% |
| STATE STREET CORP | 11/14/2024 | 25,774 | $15,413 | 0.00% | 0.10% |
| RAYMOND JAMES & ASSOCIATES | 10/18/2024 | 20,000 | $11,960 | 42.86% | 0.08% |
| CRESSET ASSET MANAGEMENT, LLC | 11/14/2024 | 19,671 | $11,763 | 0.00% | 0.08% |
| XTX TOPCO LTD | 11/14/2024 | 13,926 | $8,328 | -0.86% | 0.06% |
| MORGAN STANLEY | 11/14/2024 | 12,219 | $7,307 | 0.00% | 0.05% |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 11/13/2024 | 11,000 | $6,578 | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 7,029 | $4,203 | -0.82% | 0.03% |
| JPMORGAN CHASE & CO | 11/08/2024 | 707 | $422 | -5.48% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 258 | $154 | 85.61% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BANQUE CANTONALE VAUDOISE | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| LEO WEALTH, LLC | 10/21/2024 | 0 | $0 | -100.00% | 0.00% |
Sensei Biotherapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 25 institutional investors and hedge funds held shares of Sensei Biotherapeutics, Inc.. The most heavily invested institutionals were:
Ikarian Capital, LLC: 650,000
VANGUARD GROUP INC: 618,757
RENAISSANCE TECHNOLOGIES LLC: 215,572
BOOTHBAY FUND MANAGEMENT, LLC: 172,835
GEODE CAPITAL MANAGEMENT, LLC: 163,139
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 90,428
8.79% of Sensei Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.21 M shares in the last 24 months. This purchase volume represents approximately $992,687 in transactions.